[0148] 實施方式16.實施方式14或15的方法，其中測量測試化合物的效應(yīng)包括測量 FADS2或PPARγ，或二者的表達(dá)。
[0149] 本文所用的術(shù)語"包含（comprising) "（及其語法變異）用于包括"具有 (having)"或"包括（including)"的意思，及不排除"僅由…組成（consistingonlyof)" 的意思。本文所用的術(shù)語"a"，"an"和"the"理解為包括復(fù)數(shù)個以及單數(shù)，除非另外指示。
[0150] 上述描述例證及描述公開。此外，公開僅顯示及描述優(yōu)選的實施方式，但如上所 述，需知，其能在各種其他組合，修飾和環(huán)境中使用，和能進(jìn)行在本發(fā)明概念的范圍之內(nèi)的 變化或修飾，如在本文表達(dá)，與以上教導(dǎo)和/或關(guān)聯(lián)領(lǐng)域的技能或知識相當(dāng)。本文以上所述 的實施方式還旨在解釋由申請人已知的最佳模式，及致使其他本領(lǐng)域技術(shù)人員利用該，或 其他，實施方式中的公開及具有由特定應(yīng)用或其使用需要的各種修飾。因此，說明書未旨在 限制本發(fā)明到本文公開的形式。而且，隨附的權(quán)利要求旨在被解釋為包括替代性的實施方 式。
[0151] 各權(quán)利要求定義獨立的發(fā)明，侵權(quán)目的被認(rèn)識為包括與權(quán)利要求中特定的各種元 件或限制的相當(dāng)體。
[0152] 此說明書中引用的全部出版物和專利申請通過引用在本文合并，及為任何和全部 目的，猶如各個體出版物或?qū)＠暾埍惶貏e和個別指定為通過引用合并。當(dāng)本公開和通過 引用在本文合并的任何出版物或?qū)＠暾堉g的不一致性發(fā)生時，以本公開為準(zhǔn)。
[0153] 【參考文獻(xiàn)】
[0154] 1.SmithKR,ThiboutotDM:"Thematicreviewseries:skinlipids.Sebaceous glandlipids:friendorfoe?"JLipidRes2008, 49 (2) :271-281.
[0155] 2.PicardoM,OttavianiM,CameraE,MastrofrancescoA:"Sebaceousgland lipids".Dermatoendocrinol2009, 1(2):68-71.
[0156] 3.PochiPE,StraussJS,DowningDT: "Age-relatedchangesinsebaceous glandactivity".JInvestDermatol1979,73 (1):108-111.
[0157] 4.HuangJT,AbramsM,TlouganB,RademakerA,PallerAS:^Treatmentof Staphylococcusaureuscolonizationinatopicdermatitisdecreasesdisease severity".Pediatrics2009, 123(5):e808_814.
[0158] 5.StennKS:"Insightsfromtheasebiamouse:amolecularsebaceousgland defectleadingtocicatricialalopecia" ·JCutanPathol2001，28 (9):445-447.
[0159] 6.ZhengY，EilertsenKJ，GeL，ZhangL，SundbergJP，ProutySM，Stenn KS，ParimooS:^Scdlisexpressedinsebaceousglandsandisdisruptedinthe asebiamouse".NatGenet1999,23(3):268_270.
[0160] 7.ShizuruJA，NegrinRS，WeissmanIL:"Hematopoieticstemandprogenitor cells:clinicalandpreclinicalregenerationofthehematolymphoidsystem.''Annu RevMed2005, 56:509-538.
[0161] 8.RonfardV,RivesJM,NeveuxY,CarsinH,BarrandonY: ^Long-term regenerationofhumanepidermisonthirddegreeburnstransplantedwith autologousculturedepitheliumgrownonafibrinmatrix"·Transplantation 2000, 70(11):1588-1598.
[0162] 9.BarrandonY，GreenH:αThreeclonaltypesofkeratinocyte withdifferentcapacitiesformultiplication^.ProcNatlAcadSci USA1987,84(8):2302-2306.
[0163] 10.BarrandonY:αCrossingboundaries:stemcells，holoclones，andthe fundamentalsofsquamousepithelialrenewal"·Cornea2007,26(9Suppl1):S10-12.
[0164] 11.ZouboulisCC，SeltmannH，NeitzelH，OrfanosCE:"Establishmentand characterizationofanimmortalizedhumansebaceousglandcellline(SZ95)" ·J InvestDermatol1999,113(6):1011-1020.
[0165] 12.ThiboutotD,JabaraS,McAllisterJM,SivarajahA,GillilandK,Cong Z,ClawsonG:"Humanskinisasteroidogenictissue:steroidogenicenzymesand cofactorsareexpressedinepidermis,normalsebocytes,andanimmortalized sebocytecellline(SEB_1)".JInvestDermatol2003，120(6):905_914.
[0166] 13.LoCelsoC,BertaMA,BraunKM,FryeM,LyleS,ZouboulisCC,Watt FM:"Characterizationofbipotentialepidermalprogenitorsderivedfromhuman sebaceousgland:contrastingrolesofc-Mycandbeta-catenin" ·StemCells 2008, 26(5):1241-1252.
[0167] 14.XiaL,ZouboulisCC，JuQ:αCultureofhumansebocytesinvitro". Dermatoendocrinol2009,1(2):92-95.
[0168] 15.FumeM，KatoM，NakamuraK，NashiroK，KikuchiK，OkochiH,Miyazono K，TamakiK:"Dysregulatedexpressionoftransforminggrowthfactorbeta anditstype-Iandtype-IIreceptorsinbasal-cellcarcinoma" ·IntJCancer 1997,71 (4):505-509.
[0169] 16.DownieMM，SandersDA，KealeyT:"Modellingtheremissionofindividual acnelesionsinvitro".BrJDermatol2002, 147(5):869-878.
[0170] 17.ffollinaU,LangeD,FunaK,PausR:"Expressionoftransforminggrowth factorbetaisoformsandtheirreceptorsduringhairgrowthphasesinmice". HistolHistopathol1996, 11(2):431-436.
[0171] 18.PausR，F(xiàn)oitzikK，WelkerP，Bulfone-PausS，EichmullerS:"Transforming growthfactor-betareceptortypeIandtypeIIexpressionduringmurinehair follicledevelopmentandcycling" ·JInvestDermatol1997, 109 (4):518-526.
[0172] 19.PietenpolJA,SteinRff,MoranE,YaciukP,SchlegelR,Lyons RM，PittelkowMR，MungerK，HowleyPM，MosesHL: "TGF-beta1inhibitionofc-myc transcriptionandgrowthinkeratinocytesisabrogatedbyviraltransforming proteinswithpRBbindingdomains" ·Cell1990,61 (5):777-785.
[0173] 20.GuaschG，SchoberM，PasolliHA，ConnEB，PolakL，F(xiàn)uchsE:"Loss ofTGFbetasignalingdestabilizeshomeostasisandpromotessquamouscell carcinomasinstratifiedepithelia" ·CancerCell2007, 12 (4):313-327.
[0174] 21.ArnoldI,WattFM: "c_Mycactivationintransgenicmouseepidermis resultsinmobilizationofstemcellsanddifferentiationoftheirprogeny". CurrBiol2001，11 (8) :558-568.
[0175] 22.YangL,WangL,YangX:^DisruptionofSmad4inmouseepidermisleads todepletionoffolliclestemcells".MolBiolCell2009,20(3):882_890.
[0176] 23.RosenfieldRL，DeplewskiD，KentsisA，CilettiN:"Mechanismsof androgeninductionofsebocytedifferentiation".Dermatology1998, 196(1):43-46.
[0177] 24.Allen-HoffmannBL，SchlosserSJ,IvarieCA，SattlerCA,Meisner LF，0'ConnorSL:αNormalgrowthanddifferentiationinaspontaneously immortalizednear-diploidhumankeratinocytecellline''，NIKS.JInvestDermatol 2000, 114(3) :444-455.
[0178] 25.TroyanovskySM,GuelsteinVI,TchipyshevaTA,KrutovskikhVA,Bannikov GA:"Patternsofexpressionofkeratin17inhumanepithelia:dependencyoncell position".JCellSci1989, 93(Pt3):419-426.
[0179] 26.MagnusdottirE,KalachikovS,MizukoshiK,SavitskyD，Ishida-Yamamoto A,PanteleyevAA，CalameK:"Epidermalterminaldifferentiationdepends onBlymphocyte-inducedmaturationprotein-1 " ·ProcNatlAcadSciUSA 2007, 104(38) :14988-14993.
[0180] 27.BraunKM，NiemannC，JensenUB，SundbergJP,Si1va-Vargas V，WattFM:"Manipulationofstemcellproliferationandlineage commitment:visualisa